Since its second-quarter earnings release on July 7, Dentsply Sirona (XRAY) stock has plummeted ~20%. In this series, we’ll explore its financial performance, how its segments are performing, its recent acquisitions, its valuation metrics, and what analysts expect in the coming months.
Dentsply Sirona is a leading global manufacturer of professional dental products and technologies. It operates in two business segments—Consumables and Technologies and Equipment. Sales from the Technologies and Equipment segment include dental implants, imaging systems, treatment centers, and consumable medical device products. Sales for the segment increased from $532.8 million in the second quarter of 2017 to $548.8 million in the second quarter of 2018.
Sales from its Consumables segment include preventive, restorative, instruments and endodontics, and orthodontic dental products. Sales for the segment increased from $459.9 million in the second quarter of 2017 to $493.3 million in the second quarter of 2018.
Of the 16 analysts covering Dentsply Sirona in August, six of them have given the stock a “buy” or higher rating, and nine have given it a “hold.” One analyst has given it a “sell.” The mean rating for Dentsply stock is 2.5 with a target price of $48.67. That represents an upside potential of 23.5% over its trading price of $39.40 on August 7.
Next, let’s look at Dentsply Sirona’s top line.